Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion
Epub 2021 Mar 2.
Athanasios D Anastasilakis
Stergios A Polyzos
Maria P Yavropoulou
Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece. email@example.com.
First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Endocrinology Unit, 1st Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece.
Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.
No abstract available
Bone Density Conservation Agents*
Bone Density Conservation Agents